Brief: Kaleido Biosciences To Halt Work On Planned Phase 2 Chronic Obstructive Pulmonary Disease Study, Terminate Agreement With COPD Foundation

Kaleido Biosciences

28/01/2022 22:05

Jan 28 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES- DECIDED TO HALT WORK ON PLANNED PHASE
2
CHRONIC OBSTRUCTIVE PULMONARY DISEASE STUDY, TERMINATE ITS
AGREEMENT WITH COPD FOUNDATION

Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))